CROSS-REFERENCE TO RELATED APPLICATION
This application is a Section 371 of International Application No. PCT/CN2017/088229, filed Jun. 14, 2017, which was published in the Chinese language on Feb. 1, 2018, under International Publication No. WO 2018/019048 A1, which claims priority under 35 U.S.C.
CROSS-REFERENCE TO RELATED APPLICATION
This application claims the priority benefit of Taiwan patent application serial no. 106206569, filed on May 9, 2017. The entirety of the above-mentioned patent application is hereby incorporated by reference herein and made a part of this
FIELD OF THE INVENTION
The present invention relates to new therapeutically active and selective inhibitors of the enzyme dipeptidyl peptidase-IV (hereinafter "DPP-IV"), pharmaceutical compositions comprising the compounds and the use of such compounds for treating diseases that are associated with
اكتب أحد الأعراض أو المرض واقرأ عن الأعشاب التي قد تساعد ، واكتب عشبًا واطلع على الأمراض والأعراض التي تستخدم ضدها. * تستند جميع المعلومات إلى البحوث العلمية المنشورة